おすすめの製品
使用法
10 reactions
利用可能性
not available in Japan
保管温度
2-8°C
詳細
AnteoTech identified the following problems that researchers are having with their multiplex assays:
From these findings, they developed the AnteoBind™ Activation Kit For Multiplex Microspheres that is for use with the Luminex xMAP® system and contains the patented AnteoBind Activation Reagent.
With this Activation Kit, you can couple multiple antibodies without extra optimization for each, saving assay development time and reducing the barriers of assay transfer between diverse platforms.
AnteoBind is water based and replaces the dry chemicals you would use with the EDC method. Using AnteoBind instead of NHS/EDC chemistry can save up to 3-4 hours of lab time. Experiments have shown increased stability and functionality for antibodies and a decreased background. AnteoBind improves reproducibility between experiments by providing uniformity between surfaces. You can store your AnteoBind activated microspheres for up to 1 year.
POSTER: A Novel User Friendly Chemistry to Couple Antibodies and Challenging Proteins to Luminex MagPlex Microspheres
- Binding difficult antibodies and antigens to microspheres
- Complex protocols for inexperienced users
- Lengthy microsphere and protein preparation times prior to protein coupling
- Reproducibility between batches of protein coupled microspheres
- Limited storage of ready-to-couple microspheres
From these findings, they developed the AnteoBind™ Activation Kit For Multiplex Microspheres that is for use with the Luminex xMAP® system and contains the patented AnteoBind Activation Reagent.
With this Activation Kit, you can couple multiple antibodies without extra optimization for each, saving assay development time and reducing the barriers of assay transfer between diverse platforms.
AnteoBind is water based and replaces the dry chemicals you would use with the EDC method. Using AnteoBind instead of NHS/EDC chemistry can save up to 3-4 hours of lab time. Experiments have shown increased stability and functionality for antibodies and a decreased background. AnteoBind improves reproducibility between experiments by providing uniformity between surfaces. You can store your AnteoBind activated microspheres for up to 1 year.
POSTER: A Novel User Friendly Chemistry to Couple Antibodies and Challenging Proteins to Luminex MagPlex Microspheres
アプリケーション
Activation and coupling of Luminex Microspheres for Multiplex Immunoassays
特徴および利点
- Water based AnteoBind™ activation and coupling reagent for microspheres
- Fast assay development time making it easy to move your ELISA assay to the Luminex xMAP® system
- Compatible with both Luminex MagPlex® and MicroPlex® microspheres
- Test problematic proteins on xMAP, including those cited as not suitable for the system
- An alternative to traditional chemistries such as NHS/EDC methods with an easier to use AnteoBind protocol
- Ease of use, simply pipette AnteoBind Reagent to your chosen microspheres to activate
- Reduce reagent preparation time by 3-4 hours
- Increase antibody functionality
- Low background noise
- High reproducibility between experiments
法的情報
Anteobind is a trademark of AnteoTech Ltd
MagPlex is a registered trademark of Luminex Corp
MicroPlex is a registered trademark of Luminex Corp
xMAP is a registered trademark of Luminex Corp
キットの構成要素のみ
製品番号
詳細
- Mix&Go Activation Reagent
- Coupling Buffer
- Storage Buffer
- Low Binding Microcentrifuge Tubes
シグナルワード
Warning
危険有害性情報
危険有害性の分類
Aquatic Chronic 2 - Skin Sens. 1
保管分類コード
12 - Non Combustible Liquids
引火点(°F)
Not applicable
引火点(℃)
Not applicable
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
毒物及び劇物取締法
キットコンポーネントの情報を参照してください
PRTR
キットコンポーネントの情報を参照してください
消防法
キットコンポーネントの情報を参照してください
労働安全衛生法名称等を表示すべき危険物及び有害物
キットコンポーネントの情報を参照してください
労働安全衛生法名称等を通知すべき危険物及び有害物
キットコンポーネントの情報を参照してください
カルタヘナ法
キットコンポーネントの情報を参照してください
Jan Code
キットコンポーネントの情報を参照してください
最新バージョンのいずれかを選択してください：
Katrin Bohm et al.
Vaccine, 35(43), 5883-5889 (2017-09-19)
Worldwide about 1.5 million clinical cases of hepatitis A virus (HAV) infections occur every year and increasingly countries are introducing HAV vaccination into the childhood immunization schedule with a single dose instead of the originally licenced two dose regimen. Diagnosis
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）